Cargando…

Renin–angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study

AIM: The role of cardiovascular (CV) pharmacotherapies in patients with severe COVID-19 pneumonia remains controversial. This study aims to assess the impact of renin–angiotensin system modulation (RASi) (either angiotensin-converting enzymes (ACEIs) or angiotensin-receptor blockers (ARBs)) on COVID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landolfo, Matteo, Maino, Alberto, Di Salvo, Emanuela, Fiorini, Giulia, Peterlana, Dimitri, Borghi, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Im - Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782218/ https://www.ncbi.nlm.nih.gov/pubmed/35064437 http://dx.doi.org/10.1007/s11739-022-02929-7

Ejemplares similares

Statin therapy may protect against acute kidney injury in patients hospitalized for interstitial SARS-CoV2 pneumonia
por: Piani, Federica, et al.
Publicado: (2023)

Clinical and electrocardiographic characteristics at admission of COVID-19/SARS-CoV2 pneumonia infection
por: Denegri, Andrea, et al.
Publicado: (2021)

Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional study
por: Giorgi-Pierfranceschi, Matteo, et al.
Publicado: (2020)

Lung cancer and interstitial lung diseases: the lack of prognostic impact of lung cancer in IPF
por: Carobene, Loredana, et al.
Publicado: (2021)

Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study
por: Yahyavi, Ashkan, et al.
Publicado: (2020)

CT score in COVID-19-related pneumonia, the radiologist, and the internist. Trying to unmask who is “the good”, who is “the bad” and who is “the ugly”
por: Crisci, Giulia, et al.
Publicado: (2021)

Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience
por: Tascini, Carlo, et al.
Publicado: (2020)

Abstriche auf SARS-CoV-2 bei Tracheostomaträgern
por: Lochbaum, Robin, et al.
Publicado: (2021)

Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity
por: Lombardi, Rosa, et al.
Publicado: (2022)

Remdesivir-induced bradycardia in patients hospitalized with SARS-CoV2 infection: a possible vagally-mediated mechanism
por: Filtz, Annalisa, et al.
Publicado: (2022)

Predicting Mycoplasma pneumoniae and Chlamydophila pneumoniae in community-acquired pneumonia (CAP) pneumonia: epidemiological study of respiratory tract infection using multiplex PCR assays
por: Ishimaru, Naoto, et al.
Publicado: (2021)

Hyperkalemia: do you forget something?
por: Landolfo, Matteo, et al.
Publicado: (2022)

Update zu: SARS-CoV-2/COVID-19 – Epidemiologie und Prävention
por: Salzberger, Bernd, et al.
Publicado: (2021)

Impact of SARS-CoV-2 infection in patients with hereditary hemorrhagic telangiectasia: epidemiological and clinical data from the comprehensive Italian retrospective multicenter study
por: Suppressa, Patrizia, et al.
Publicado: (2023)

Impact of 2020 SARS-CoV-2 outbreak on telemedicine management of cardiovascular disease in Italy
por: Molinari, Giuseppe, et al.
Publicado: (2020)

Chest X-ray findings in a large cohort of 1117 patients with SARS-CoV-2 infection: a multicenter study during COVID-19 outbreak in Italy
por: Vespro, Valentina, et al.
Publicado: (2020)

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies
por: Albini, Adriana, et al.
Publicado: (2020)

Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients
por: Arcari, Luca, et al.
Publicado: (2020)

Lung ultrasound in the follow-up of severe COVID-19 pneumonia: six months evaluation and comparison with CT
por: Russo, Giulia, et al.
Publicado: (2022)

Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves
por: Miele, Luca, et al.
Publicado: (2023)

The effect of laboratory-verified smoking on SARS-CoV-2 infection: results from the Troina sero-epidemiological survey
por: Tomaselli, Venera, et al.
Publicado: (2022)

Early echocardiographic findings in patients hospitalized for COVID-19 pneumonia: a prospective, single center study
por: Ceriani, Elisa, et al.
Publicado: (2021)

Sex and gender differences in community-acquired pneumonia
por: Corica, Bernadette, et al.
Publicado: (2022)

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
por: Testa, Sophie, et al.
Publicado: (2020)

Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions
por: Crescioli, Giada, et al.
Publicado: (2020)

Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence
por: Sarzani, Riccardo, et al.
Publicado: (2021)

Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital
por: Carnicelli, Annamaria, et al.
Publicado: (2021)

Vitamin D deficiency is associated with higher risks for SARS-CoV-2 infection and COVID-19 severity: a retrospective case–control study
por: Israel, Ariel, et al.
Publicado: (2022)

Atrial fibrillation in pneumonia: what clinical implications at long-term?
por: Vitolo, Marco, et al.
Publicado: (2022)

Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study
por: Trevisan, Caterina, et al.
Publicado: (2023)

RDW-based clinical score to predict long-term survival in community-acquired pneumonia: a European derivation and validation study
por: Melchio, Remo, et al.
Publicado: (2021)

Delayed mechanical ventilation with prolonged high-flow nasal cannula exposure time as a risk factor for mortality in acute respiratory distress syndrome due to SARS-CoV-2
por: López-Ramírez, Viviana Yiset, et al.
Publicado: (2023)

Handgrip strength is associated with adverse outcomes in patients hospitalized for COVID-19-associated pneumonia
por: Pucci, Giacomo, et al.
Publicado: (2022)

Inhibitors of the renin–angiotensin system and SARS-CoV-2 infection
por: Kessler, Thorsten, et al.
Publicado: (2020)

Drugs acting on the renin–angiotensin system and SARS-CoV-2
por: Vitiello, Antonio, et al.
Publicado: (2021)

Serum TRAIL predicts severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study
por: Hua, Dong-Xu, et al.
Publicado: (2022)

Renal effects of Sacubitril/Valsartan in heart failure with reduced ejection fraction: a real life 1-year follow-up study
por: Spannella, Francesco, et al.
Publicado: (2019)

Prevalence and clinical impact of VIral Respiratory tract infections in patients hospitalized for Community-Acquired Pneumonia: the VIRCAP study
por: Tatarelli, P., et al.
Publicado: (2019)

Effect of corticosteroids on myocardial injury among patients hospitalized for community-acquired pneumonia: rationale and study design. The colosseum trial
por: Violi, Francesco, et al.
Publicado: (2019)

Serological response to COVID-19 pneumonia and increasing severity over 18 months in a prospective cohort of hospitalized patients
por: Grau Gómez, Gemma, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oacqkkgu420e7kdnhu1iiggaet